Gestational age and cancer risk up to young adulthood in Swedish population born 1974 to 2013: A population-based cohort study.


Journal

International journal of cancer
ISSN: 1097-0215
Titre abrégé: Int J Cancer
Pays: United States
ID NLM: 0042124

Informations de publication

Date de publication:
15 04 2022
Historique:
revised: 27 09 2021
received: 01 03 2021
accepted: 11 10 2021
pubmed: 3 12 2021
medline: 25 2 2022
entrez: 2 12 2021
Statut: ppublish

Résumé

We examined the association between gestational age and risk of any primary cancer and observed whether the risk patterns differed by sex, birth weight for gestational age categories, cancer site and age of onset. All people live-born in Sweden 1974 to 2013 were prospectively followed up from birth until 2016 using national registers. Gestational age was extracted from the Medical Birth Register and primary malignant cancer diagnoses were from the Swedish cancer register. The adjusted hazard ratios (aHR) for any primary cancer according to weekly gestational age and gestational age categories were determined using cox proportional hazards models adjusted for birth year and parental age. The study included 3 137 691 people; 180 363 (5.8%) born preterm and 254 790 (8.1%) born postterm. They were followed up for 71 691 112 person-years, to a maximum of 43 years and recorded 22 604 new cancers. Although aHRs for the predefined GA categories were only increased for moderate to late preterm delivery (aHR 1.07, 95% CI 1.01-1.14), gestational week-specific aHRs were increased for gestational weeks 30 to 35, with greatest aHR observed for 31 weeks (aHR 1.18, 95% CI 1.05-1.32). Increased cancer risk related to shorter gestational ages were observed particularly for women, those born small for gestational age, childhood cancers and for cancers originating at certain sites (eg, testicular and liver cancer). We provide the first evidence that those born between 30 and 35 weeks gestation may have increased risk of any primary malignant cancer up to young adulthood. Additionally, increasing gestational ages may reduce the risk of testicular and liver cancer.

Identifiants

pubmed: 34855204
doi: 10.1002/ijc.33886
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1269-1280

Informations de copyright

© 2021 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.

Références

Harrison MS, Goldenberg RL. Global burden of prematurity. Semin Fetal Neonatal Med. 2016;21:74-79.
Paquette K, Coltin H, Boivin A, Amre D, Nuyt A-M, Luu TM. Cancer risk in children and young adults born preterm: a systematic review and meta-analysis. PLoS One. 2019;14:e0210366.
Crump C, Sundquist K, Winkleby MA, Sieh W, Sundquist J. Gestational age at birth and risk of testicular cancer. Int J Cancer. 2012;131:446-451.
Ekbom A, Erlandsson G, Hsieh C, Trichopoulos D, Adami H-O, Cnattingius S. Risk of breast cancer in prematurely born women. J Natl Cancer Inst. 2000;92:840-841.
Kaijser M, Akre O, Cnattingius S, Ekbom A. Preterm birth, birth weight, and subsequent risk of female breast cancer. Br J Cancer. 2003;89:1664-1666.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.
Pritchard-Jones K, Pieters R, Reaman GH, et al. Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries. Lancet Oncol. 2013;14:e95-e103.
Dagenais GR, Leong DP, Rangarajan S, et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2020;395:785-794.
Crump C, Sundquist J, Winkleby MA, Sundquist K. Gestational age at birth and mortality from infancy into mid-adulthood: a national cohort study. Lancet Child Adolesc Health. 2019;3:408-417.
Risnes K, Bilsteen JF, Brown P, et al. Mortality among young adults born preterm and early term in 4 nordic nations. JAMA Netw Open. 2021;4:e2032779.
Benchimol EI, Smeeth L, Guttmann A, et al. The reporting of studies conducted using observational routinely-collected health data (RECORD) statement. PLoS Med. 2015;12:e1001885.
Cnattingius S, Ericson A, Gunnarskog J, Källén B. A quality study of a medical birth registry. Scand J Soc Med. 1990;18:143-148.
Preterm Birth [Internet]. https://www.who.int/news-room/fact-sheets/detail/preterm-birth. Accessed October 2, 2020.
Quinn J-A, Munoz FM, Gonik B, et al. Preterm birth: case definition & guidelines for data collection, analysis, and presentation of immunisation safety data. Vaccine. 2016;34:6047-6056.
The Swedish Cancer Register [Internet]. Socialstyrelsen. https://www.socialstyrelsen.se/en/statistics-and-data/registers/register-information/swedish-cancer-register/. Accessed October 2, 2020.
Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish cancer register-a sample survey for year 1998. Acta Oncol. 2009;48:27-33.
Smedby B, Schiøler G, Nordisk Medicinal-Statistisk Komité. Health Classifications in the Nordic Countries: Historic Development in a National and International Perspective 2006 00 = Hälsoklassifikationer i de nordiska länderna. Kbh.; Albertslund: Nordic Medico Statistical Committee; Kan bestilles hos: Schultz Information; 2006.
Ananth CV, Vintzileos AM. Distinguishing pathological from constitutional small for gestational age births in population-based studies. Early Hum Dev. 2009;85:653-658.
Ludvigsson JF, Almqvist C, Bonamy A-KE, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31:125-136.
Ludvigsson JF, Svedberg P, Olén O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34:423-437.
Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol. 1997;145:72-80.
Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
Chen X. Score Test of Proportionality Assumption for Cox Models. 2008. Los Angeles, CA: Statistical Consulting Group, UCLA, http://www.ats.ucla.edu/stat/.
Spector LG, Puumala SE, Carozza SE, et al. Cancer risk among children with very low birth weight. Pediatrics. 2009;124:96-104.
Cook MB, Akre O, Forman D, Madigan MP, Richiardi L, McGlynn KA. A systematic review and meta-analysis of perinatal variables in relation to the risk of testicular cancer-experiences of the son. Int J Epidemiol. 2010;39:1605-1618.
Hogan AH, Bellin E, Douglas L, Levin TL, Esteban-Cruciani N. Radiation exposure of premature infants beyond the perinatal period. Hosp Pediatr. 2018;8:672-678.
Gurney JK, McGlynn KA, Stanley J, et al. Risk factors for cryptorchidism. Nat Rev Urol. 2017;14:534-548.
Clayton PE, Cianfarani S, Czernichow P, Johannsson G, Rapaport R, Rogol A. Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metabol. 2007;92:804-810.
Marlow EC, Ducore J, Kwan ML, et al. Leukemia risk in a cohort of 3.9 million children with and without Down syndrome. J Pediatr. 2021;234:172-180.e3.

Auteurs

Monica S M Persson (MSM)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Weiyao Yin (W)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.

Nora Döring (N)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Kari Risnes (K)

NTNU, Trondheim, Norway.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, Lyon, France.

Eva Steliarova-Foucher (E)

International Agency for Research on Cancer, Lyon, France.

Sven Sandin (S)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Department of Psychiatry, Ichan School of Medicine at Mount Sinai, New York, New York, USA.
Seaver Autism Center for Research and Treatment at Mount Sinai, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH